Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.

Letari O, Booth C, Bonazzi A, Garofalo P, Makovec F, Rovati LC, Caselli G

Open source

DOI
10.1007/s00280-009-1224-1
Published
2010 Oct
Container
Cancer chemotherapy and pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00280-009-1224-1,
  title = {Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.},
  author = {Letari O and Booth C and Bonazzi A and Garofalo P and Makovec F and Rovati LC and Caselli G},
  year = {2010},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-009-1224-1},
  url = {https://doi.org/10.1007/s00280-009-1224-1}
}

RIS

TY  - JOUR
TI  - Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.
AU  - Letari O
AU  - Booth C
AU  - Bonazzi A
AU  - Garofalo P
AU  - Makovec F
AU  - Rovati LC
AU  - Caselli G
PY  - 2010
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-009-1224-1
UR  - https://doi.org/10.1007/s00280-009-1224-1
ER  - 

APA

O, L., C, B., A, B., P, G., F, M., LC, R., & G, C. (2010). Efficacy of CR3294, a new benzamidine derivative, in the prevention of 5-fluorouracil-induced gastrointestinal mucositis and diarrhea in mice.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-009-1224-1

Source records